Atlas Trials

Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study

Clinical trial NCT04260269 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT04260269
Sponsor
Helsinki University Central Hospital
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Solid Tumor
Start date
2018-06-01
Primary completion
2027-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.